Table 2. Correlations between clinicopathological parameters and GMF-β expression in tumor cells of glioma.
| Parameters | GMF-β high (>2, n = 71) | GMF-β low (≤2, n = 75) | P-value | ||
|---|---|---|---|---|---|
| N | Percentage (%) | N | Percentage (%) | ||
| Age (years) | |||||
| ≥45 | 35 | 49 | 31 | 41 | 0.334 |
| <45 | 36 | 51 | 44 | 59 | |
| Gender | |||||
| Male | 46 | 65 | 43 | 57 | 0.356 |
| Female | 25 | 35 | 32 | 43 | |
| WHO grade | |||||
| LG | 16 | 23 | 31 | 41 | 0.015 |
| HG | 55 | 77 | 44 | 59 | |
| KPS | |||||
| ≥80 | 40 | 56 | 45 | 60 | 0.654 |
| <80 | 31 | 44 | 30 | 40 | |
| Ki-67 index | |||||
| ≥5 | 47 | 66 | 37 | 49 | 0.039 |
| <5 | 24 | 34 | 38 | 51 | |
| Predominant side | |||||
| L | 34 | 48 | 31 | 41 | 0.585 |
| R | 34 | 48 | 42 | 56 | |
| Other | 3 | 4 | 2 | 3 | |
| Predominant lobe | |||||
| Frontal | 34 | 48 | 35 | 47 | 0.192 |
| Temporal | 26 | 37 | 20 | 27 | |
| Other | 11 | 15 | 20 | 26 | |
Abbreviations: KPS, Karnofsky performance status; LG, low grade; HG, high grade.